机构

• 上海药物研究所 [92]
• 过程工程研究所 [14]
• 上海生物化学与细胞... [13]
• 合肥物质科学研究院 [13]
• 上海硅酸盐研究所 [11]
• 西北高原生物研究所 [9]
• 更多

采集方式

• OAI收割 [228]
• iSwitch采集 [15]

内容类型

• 期刊论文 [237]
• 会议论文 [4]
• 学位论文 [2]

发表日期

• 2024 [4]
• 2023 [11]
• 2022 [22]
• 2021 [25]
• 2020 [24]
• 2019 [22]
• 更多

学科主题

• Oncology [4]
• Cell Biolo... [3]
• 物理化学 [3]
• General & ... [2]
• Materials ... [2]
• Science & ... [2]
• 更多

筛选

浏览/检索结果: 共243条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Passive microfluidic devices for cell separation 期刊论文  OAI收割 BIOTECHNOLOGY ADVANCES, 2024, 卷号: 71, 页码: 25 作者:  Zhang, Tianlong;  Di Carlo, Dino;  Lim, Chwee Teck;  Zhou, Tianyuan;  Tian, Guizhong   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/04/03 Passive microfluidics  Cell separation  Label-free  Hybrid  Intelligent   Activating CD8+ T Cells by Pt(IV) Prodrug-Based Nanomedicine and aPD-L1 Antibody for Enhanced Cancer Immunotherapy 期刊论文  OAI收割 ADVANCED MATERIALS, 2024, 页码: 15 作者:  Wang, Bin;  Zhou, Jingyu;  Li, Ruitong;  Tang, Dongsheng;  Cao, Zheng   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/04/09 chemotherapy  immunotherapy  immunogenic cell death  tumor immune microenvironment   Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress 期刊论文  OAI收割 PHARMACEUTICS, 2024, 卷号: 16, 期号: 2, 页码: 21 作者:  Cheng, Shigao;  Wang, Huiyuan;  Kang, Xuejia;  Zhang, Hui   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/04/09 osteosarcoma  suppressive immune environment  nanoparticles  immunotherapy   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 卷号: 125, 页码: 15 作者:  Feng, Qilin;  Hu, Ke;  Hu, Huifang;  Lu, Yumeng;  Zhang, Hui   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/01/16 DLBCL  ROS  DNA damage  JNK  Mitochondrial dysfunction   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke;  Xu, Li;  Feng, Qilin   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   Biocompatible Ferrofluid-Based Millirobot for Tumor Photothermal Therapy in Near-Infrared-II Window 期刊论文  OAI收割 ADVANCED HEALTHCARE MATERIALS, 2023, 页码: 12 作者:  Ji, Yiming;  Bai, Xue;  Sun, Hongyan;  Wang, Luyao;  Gan, Chunyuan   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/02/22 ferrofluid robots  biocompatibility  targeted therapy   Development of a novel 18F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression 期刊论文  OAI收割 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 页码: 13 作者:  Bu, Lihong;  Ma, Xiaowei;  Ji, Aiyan;  Geng, Kaijun;  Feng, Hongyan   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/12/19 Mesenchymal epithelial transition receptor  Gliomas  [18F]-AZC  PET  Quinoline derivative compound   Amplifying oxidative stress utilizing multiband luminescence of lanthanide nanoparticles for eliciting systemic antitumor immunity 期刊论文  OAI收割 CHEMICAL ENGINEERING JOURNAL, 2023, 卷号: 468, 页码: 12 作者:  Wu, Fengxia;  Chen, Haoran;  Li, Qiqing;  Liu, Ruiqi;  Suo, Yongkuan   |  收藏  |  浏览/下载：24/0  |  提交时间：2023/10/17 Lanthanide-doped nanoparticles  Phototherapy  Ferroptosis  Immunogenic cell death  NIR-IIb imaging  Oxidative stress   Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 9 作者:  Li, Hua-ying;  Chen, Yi-li;  Deng, Xiang-nan;  Li, Huan-huan;  Tan, Jie   |  收藏  |  浏览/下载：24/0  |  提交时间：2023/10/17 cancer immunotherapy  B7-H3  PD-L1  bispecific antibodies  VHH  antibody-dependent cell-mediated cytotoxicity (ADCC)